Monday, 28 November 2016

Teva Pharm to market medical cannabis inhaler in Israel

JERUSALEM (Reuters) - Israel's Teva Pharmaceuticals has partnered with Tel Aviv-based Syqe Medical to market in Israel medical cannabis for pain management that is administered with an inhaler.


No comments:

Post a Comment